Yvonne Enman - Search Results

Year	Number of Results
2020	1
2021	4
2022	3
2023	5
2024	4

1

Distinct gene dysregulation patterns herald precision medicine potentiality in systemic lupus erythematosus.

Lindblom J, Toro-Domínguez D, Carnero-Montoro E, Beretta L, Borghi MO, Castillo J, Enman Y; PRECISESADS Clinical Consortium; Mohan C, Alarcón-Riquelme ME, Barturen G, Parodis I. Lindblom J, et al. Among authors: enman y. J Autoimmun. 2023 Apr;136:103025. doi: 10.1016/j.jaut.2023.103025. Epub 2023 Mar 28. J Autoimmun. 2023. PMID: 36996699 Free article.

2

Impact of Belimumab on Patient-Reported Outcomes in Systemic Lupus Erythematosus: Insights from Clinical Trials and Real-World Evidence.

Gomez A, Enman Y, Parodis I. Gomez A, et al. Among authors: enman y. Patient Relat Outcome Meas. 2023 Jan 19;14:1-13. doi: 10.2147/PROM.S369584. eCollection 2023. Patient Relat Outcome Meas. 2023. PMID: 36699199 Free PMC article. Review.

3

OMERACT 2023 Systemic Lupus Erythematosus Special Interest Group: Winnowing and Binning Preliminary Candidate Domains for the Core Outcome Set.

Nielsen W, Strand V, Simon LS, Parodis I, Kim AHJ, Desai M, Enman Y, Wallace D, Chaichian Y, Navarra S, Aranow C, MacKay M, Trotter K, Tayer-Shifman OE, Duarte-Garcia A, Shan Tam L, Ugarte-Gil MF, PonsEstel GJ, Reynolds JA, Nikpour M, Hoi A, Romero-Diaz J, Papachristos D, Aggarwal A, Mok CC, Fujio K, Ramsey-Goldman R, Howe A, Kia BN, Bonilla D, Thumboo J, Mosca M, Aringer M, Johnson SR, Drucker AM, Morand E, Bruce I, Touma Z; OMERACT SLE Working Group. Nielsen W, et al. Among authors: enman y. Semin Arthritis Rheum. 2024 Apr;65:152380. doi: 10.1016/j.semarthrit.2024.152380. Epub 2024 Jan 14. Semin Arthritis Rheum. 2024. PMID: 38281467

4

Obesity is associated with pain and impaired mobility despite therapy in systemic lupus erythematosus.

Borg A, Lindblom J, Gomez A, Soltani A, Enman Y, Heintz E, Regardt M, Grannas D, Emamikia S, Parodis I. Borg A, et al. Among authors: enman y. Front Med (Lausanne). 2023 Aug 24;10:1247354. doi: 10.3389/fmed.2023.1247354. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37692782 Free PMC article.

5

Impact of remission and low disease activity on health-related quality of life in patients with systemic lupus erythematosus.

Emamikia S, Oon S, Gomez A, Lindblom J, Borg A, Enman Y, Morand E, Grannas D, van Vollenhoven RF, Nikpour M, Parodis I. Emamikia S, et al. Among authors: enman y. Rheumatology (Oxford). 2022 Nov 28;61(12):4752-4762. doi: 10.1093/rheumatology/keac185. Rheumatology (Oxford). 2022. PMID: 35302581 Free PMC article.

6

Impact of overweight and obesity on patient-reported health-related quality of life in systemic lupus erythematosus.

Gomez A, Hani Butrus F, Johansson P, Åkerström E, Soukka S, Emamikia S, Enman Y, Pettersson S, Parodis I. Gomez A, et al. Among authors: enman y. Rheumatology (Oxford). 2021 Mar 2;60(3):1260-1272. doi: 10.1093/rheumatology/keaa453. Rheumatology (Oxford). 2021. PMID: 32918459 Free PMC article.

7

How Can We Enhance Adherence to Medications in Patients with Systemic Lupus Erythematosus? Results from a Qualitative Study.

Emamikia S, Gentline C, Enman Y, Parodis I. Emamikia S, et al. Among authors: enman y. J Clin Med. 2022 Mar 27;11(7):1857. doi: 10.3390/jcm11071857. J Clin Med. 2022. PMID: 35407466 Free PMC article.

8

EQ-5D full health state after therapy heralds reduced hazard to accrue subsequent organ damage in systemic lupus erythematosus.

Lindblom J, Zetterberg S, Emamikia S, Borg A, von Perner G, Enman Y, Heintz E, Regardt M, Grannas D, Gomez A, Parodis I. Lindblom J, et al. Among authors: enman y. Front Med (Lausanne). 2022 Dec 20;9:1092325. doi: 10.3389/fmed.2022.1092325. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36606059 Free PMC article.

9

EQ-5D-3L full health state discriminates between drug and placebo in clinical trials of systemic lupus erythematosus.

Lindblom J, Gomez A, Borg A, Emamikia S, Ladakis D, Matilla J, Pehr M, Cobar F, Enman Y, Heintz E, Regardt M, Parodis I. Lindblom J, et al. Among authors: enman y. Rheumatology (Oxford). 2021 Oct 2;60(10):4703-4716. doi: 10.1093/rheumatology/keab080. Rheumatology (Oxford). 2021. PMID: 33502473 Free PMC article.

10

Sensitivity analysis of EQ-5D-3L index scores in terms of discriminative and known-groups validity in SLE: introducing Adequate Health State.

Hua N, Gomez A, Lindblom J, Emamikia S, Enman Y, Grannas D, Heintz E, Regardt M, Parodis I. Hua N, et al. Among authors: enman y. Rheumatology (Oxford). 2023 Dec 1;62(12):3916-3923. doi: 10.1093/rheumatology/kead140. Rheumatology (Oxford). 2023. PMID: 36946293 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

17 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year